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Abstracts. The possibility that Ia antigens are unique among H-2 antigens in their relationship 
to the Fc receptor was investigated in an EA rosette assay. Antibody specific for antigens in various 
regions of the H-2 complex was incubated with mouse cells, and the ability of the cells to form 
rosettes with antibody-coated chicken erythrocytes was tested. Antibody raised against the H-2 
antigens of Ia-negative tumor cells was highly effective in inhibiting rosette formation. A variety 
of antisera against K-, 1-, and D-region antigens tested in recombinant mice inhibited EA rosette 
formation, suggesting that antigens in each of these regions could be detected in rosette inhibition. 
The F(ab')2 fragments of all antisera tested also produced specific EA rosette inhibition. Finally, 
antibody against la antigens failed to inhibit bone marrow RFCs, although antibody against H-2 K 
and H-2D antigens did inhibit. Although H-2 serology is in a state of rapid change at present, 
it must be concluded that in this assay, antibody against antigens in the K and D regions as well 
as the 1 region can inhibit EA rosette formation. Inhibition of these rosettes by anti H-2 sera 
is therefore not due to a special association of Ia antigens with Fc receptors. 
Introduction 
The Fc  receptor  is a cel l-surface c o m p o n e n t  d e m o n s t r a b l e  on a wide var ie ty  
of  n o r m a l  and  neoplas t ic  cells (for review see Kerbe l  and  Davies  1974). It has 
po ten t ia l  s ignif icance in many  i m m u n o l o g i c  p h e n o m e n a ,  inc luding  cyto toxic i ty ,  
al lergy,  regu la t ion  of  the immune  response,  to le rance  and  enhancement ,  and  
others.  We  have been a t t empt ing  to es tabl ish  the re la t ionsh ip  o f  the  Fc  recep tor  
to o ther  cel l-surface componen t s  o f i m m u n o g e n e t i c  interest  by assessing the abi l i ty  
o f  a n t i b o d y  agains t  these c o m p o n e n t s  to inhibi t  Fc  recep to r  b inding.  Tha t  such 
re la t ionships  might  be es tabl ished in this  way is suggested by a recent  r epor t  
in which b ind ing  o f  aggrega ted  Ig to  B-cell Fc  recep tors  was inh ib i ted  by an t ibody  
a g a i n s t / - r e g i o n  ant igens,  imply ing  a close assoc ia t ion  be tween B-cell Fc  receptors  
and  l a  ant igens  (Dick le r  and  Sachs 1974). 
In prev ious  studies we d e m o n s t r a t e d  tha t  the Fc  recep tor  o f  cy to tox ic  K 
cells is no t  inhib i ted  by the F(ab ' )2  o f  an t i - I a  a n t i b o d y  (Sch i r rmacher  et  al. 
1975a, b), suggest ing tha t  this recep tor  is no t  ident ica l  or  closely assoc ia ted  
with  l a  ant igen.  F u r t h e r m o r e  it was shown tha t  the F (ab ' ) z  o f  an t ibod ie s  agains t  
Ia  and  o ther  B-cell ant igens  inh ib i t ed  roset te  f o rma t ion  be tween  a n t i b o d y - c o a t e d  
e ry th rocy tes  (EA)  and  l y m p h  node  lymphocytes .  This  la t te r  result  ind ica ted  tha t  
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E A  rose t t e  i n h i b i t i o n  i n v o l v e d  d i rec t  b ind ing  o f  the  a n t i b o d y  to  the  rose t t e -  
f o r m i n g  cell ( R F C ) .  H o w e v e r ,  the  mu l t i p l i c i t y  o f  the  a n t i b o d i e s  [ant i-Ia ,  ant i -  
Ly  4.2, a n t i m o u s e  i m m u n o g l o b u l i n  (MIg) ,  a n t i m o u s e  b o n e - m a r r o w - d e r i v e d  lym-  
p h o c y t e  an t igen  ( M B L A ) ]  c a p a b l e  o f  i nh ib i t i ng  E A - R F C ,  p r e c l u d e d  iden t i ty  
b e t w e e n  Fc  r ecep to r s  and  any  one  an t i gen  as an  e x p l a n a t i o n  o f  the  inh ib i t ion .  
In  the  p r e sen t  r e p o r t  we e x a m i n e d  the  h y p o t h e s i s  t ha t  Ia  an t igens  were  u n i q u e  
a m o n g  an t igens  o f  the  H - 2  c o m p l e x  in the i r  r e l a t i o n s h i p  to the  Fc  recep to r .  
A n t i s e r a  aga ins t  H-2  K,  la ,  a n d  H-2  D an t igens  were  all f o u n d  to inh ib i t  specif ica l ly  
E A - R F C .  T h e  F (ab ' ) z  f r a g m e n t s  f r o m  these  a n t i b o d i e s  were  as s t rong ly  i n h i b i t o r y  
as the  in t ac t  a n t i b o d y  molecu les .  T h e  i m m u n o g e n e t i c  i m p l i c a t i o n s  o f  these  resul t  
will  be d iscussed.  
Materials and Methods 
Culture Medium. The medium was Eagle's MEM (The Wellcome Research Laboratories, Kent, 
England) with 0.02 M Hepes (Wellcome) and gentamycin (5/ag/ml), and 5% fetal calf serum (Flow 
Laboratories, Inc., Rockville, Maryland). Rosette assays were done:in 63.5 • 9.5 mm round bottomed 
polystyrene tubes (LP/3 tubes, Luckham Limited, Burgess Hill, Sussex, England). 
Animals. Young adult male and female animals were used. Strains CBA/H, BALB/c, DBA/I, 
DBA/2, C57BL/6, C57BL/10Sn (abbreviation BI0) BI0.A, BI0.D2, and BI0.BR were bred in the 
London Hospital Medical College or were obtained from the Laboratory Animal Centre, Carshaltom 
England. Strains BI0.A(2R), BI0.A(5R), BI0.T(6R), BI0.S(7R), HTG, A.TH, A.TL, and A.SW 
were bred in this laboratory from breeding pairs obtained from Dr. Peter D6mant, Institute of 
Experimental Biology and Genetics, Praha, Czechoslovakia; from Dr. Donald C. Shreffier, Univer- 
sity of Michigan, Ann Arbor, Michigan; and from Dr. H.O. McDevitt and Ms. B. Deak, Stanford 
University, Stanford, California. The H-2 haplotypes of the recombinant strains used are given 
in Table 1. 
Antisera. Table 2 contains details of the anti H-2 sera used. Sera A, B, C, and G were prepared 
by repeated intraperitoneal injection of l 0  7 spleen or tumor cells at weekly intervals for 6 weeks. 
The P815Y and Meth A tumors were obtained from the Chester Beatty Research Institute, London 
S.W.3 and were maintained by repeated intraperitoneal passage in DBA/2 and BALB/c mice, respec- 
tively. Sera D, E, F, H, I, J~ K were obtained from the Transplantation Immunology Branch~ NIAID, 
NIH, Bethesda, Maryland. Details of the raising and testing of these sera are contained in the 
Table 1. H-2 Haplotypes of Recombinant Strains Used 
Strain 1t-2 H-2 Regions" 
Haplotype 
K 1 
AA I-B B E  A C  
S D 
BI0.A a 
B 10.A(2 R ) h2 
B10.A(5R) i5 
B I 0.T(6R) ),2 
BI 0.S(7R), A.TH t2 
B10.AKM m 
A.TL t l  
HTG g 
C3H.OL ol 
k k k k o r d  d d d 
k k k k o r d  d d b 
b b b k o r d  d d d 
q q q q q q d 
s s s s s s d 
k k k k k k q 
s k k k k k d 
d d d d d d b 
d d d d d k k 
a Shreffier and David 1975 and unpublished data. 
Fc Receptor Inhibition by Anti H-2 
Table 2. Specificity of  11-2 Antisera Used 
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Serum Potential H-2 Specificity 
H-2K a ] b H-2D" 
A CBA/H anti BALB/c (many) 6, 8, 11 (many) 
B CBA/H anti PSI5Y tumor  (many) - (many) 
C CBA/H anti Meth A tumor  (many) - (many) 
D (BI0•  anti B10.M 8, 9, 37 1, 14 - 
E (B10xB10.A)F1 anti B10.D2 31 11, 16 - 
F ( B l 0 x  B10.RIII)F x anti B10.A(2R) 23 1, 2, 15 -- 
G ( B I 0 x C 3 H . O L ) F  1 anti B10.A(5R) -- - 4, 13, 41, 42, 43, 44 
H (BI0 .AKM • 129)F1 anti B10.A 6 4 
I (B10• LP.RIII)F 1 anti BI0.A(5R) 15 4, 13, 41, 42, 43, 44 
J (BI0.BR z LP.RIII)F 1 anti B10.A(2R) - - 2, 28, 29, 56 
K ( C 3 H . S W x  HTG)F~ anti C3H-H-2 ~ 1 - 1, 32 
L A.TH anti A.TL - 1, 2, 3, 7, 15 - 
M (A.TH x BI0)F1 anti A.TL - 1, 2, 7, 15 - 
a For H-2 chart see Dbmant  1973. 
b For I a . l -10  see Shreffier and David 1975; la.11-16, David, unpublished data. 
NIH catalogue and its 1973 and 1974 supplements  (Snell 1968). The raising and testing of sera 
L and M were described previously (David et al. 1973, Shreffier and David 1975). 
Rabbit  antichicken antibody (RACA) was prepared by weekly intravenous injection of l09 
fresh washed CRBC for 5 weeks. The preparation of lgG and F(ab')2 fragments from rabbit and 
mouse antisera has been described elsewhere (Schirrmacher et al. 1975a). 
EA rosettes. Fresh chicken red cells were washed twice in MEM. To 1 ml of a 2% suspension, 
30 ~tl of  purified R A C A  IgG was added and the mixture incubated for 30 minutes at room temperature. 
The cells were then washed twice and resuspended in 1 ml. 
Mouse spleen and lymph node cells were prepared in the usual manner.  No at tempt was made 
to remove adherent or phagocytic cells. Thymus  cells were prepared by teasing thymuses,  taken 
from young mice, through a fine mesh, taking care to remove parathymic lymph nodes. Bone marrow 
cells were obtained by irrigating the femoral marrow cavity with heparinized medium. All cells 
were washed twice and made up to 6 • 106/ml. When rosette inhibition by antisera was to be studied, 
10 ixl of  ant iserum and 500 p,1 of cells were incubated together for 30 minutes at room temperature. 
Then the cells were washed once and resuspended at 3 or 6 x 106/ml. To prepare rosettes, 50 ~tl 
of cells, 50 )al of  medium, and 50 p.l of  CRBC coated with RACA were spun down at 150g for 
3 minutes at 4~ and were kept on ice until the counting was complete. The pellet was 
resuspended and the number  of  viable mouse cells, with two or more chicken ceils attached, was 
counted in a Neubauer  counting chamber under  phase-contrast  illumination. Four  counts  of  the 
rosette forming cells and total nucleated mouse cells were performed on each sample and the percentage 
of rosette forming cells was calculated. Usually 800 mouse cells were assessed per sample. The 
results of the rosette determinations were expressed as the arithmetic mean and standard deviation 
of the quadruplicate counts. The percentage of rosette-forming cells, after preincubation with anti- 
serum, was then compared with the percentage of rosette-forming cells after preincubation with 
identical amounts  of  normal mouse serum. Other controls in the system included uncoated chicken 
cells plus mouse cells (which never showed rosettes) and antibody-coated chicken red cells alone 
(for assessment of  agglutination). 
Results 
T h e  E A  R o s e t t e  A s s a y .  W h e n  m o u s e  l y m p h  n o d e  o r  s p l e e n  ce l l s  w e r e  c e n t r i -  
f u g e d  w i t h  a n t i b o d y - c o a t e d  c h i c k e n  r e d  c e l l s  ( E A ) ,  s o m e  o f  t h e  m o u s e  ce l l s  
f o r m e d  r o s e t t e s  ( s ee  F i g .  l ) .  T h e  i m p o r t a n t  p a r a m e t e r s  i n  t h i s  t e c h n i q u e  w e r e :  
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Fig. 1. Typical EA rosettes formed between mouse spleen cells and antibody-coated chicken erythro- 
cytes. Six rosettes, several free lymphocytes, and many free chicken erythrocytes are shown 
(a) purification of the antichicken erythrocyte antibody (RACA) to remove 19S 
antibody; (b) titration of the IgG preparation to find the highest subagglutinating 
concentration; (c) establishment of optimum numbers and ratios of test cells 
and EA. The total dependence of the rosettes on Fc receptor binding was demon- 
strated as follows: (a) when the erythrocytes were coated with RACA from 
which Fc portions had been removed by pepsin-digestion, no rosettes were 
formed; (b) preincubation of the rosette-forming cells with nonrelevant immune 
complexes or with aggregated IgG inhibited EA rosette formation. 
The tissue distribution of EA-RFC was investigated. The percentage of 
EA-RFC found was 40 to 50 with unfractionated spleen cells, 20 to 30 with 
lymph node cells, 20 to 40 with bone marrow ceils, and less than 1 with thymus 
cells. The great majority of the EA-RFC in spleen and lymph node cell prepara- 
tions are small lymphocytes morphologically (probably B lymphocytes, see Dis- 
cussion), whereas in bone marrow-cell preparations the majority of EA-RFC 
are large blast-like cells. 
Inhibition of  EA Rosettes by Anti-H-2 Sera with or without Anti-Ia Activity. 
When mouse ceils are incubated with antiserum directed against their H-2 specifi- 
cities, they lose their capacity to form EA rosettes. This is illustrated in Table 3. 
Antiserum A, raised by injection of spleen cells, is expected to contain antibody 
Fc Receptor Inhibition by Anti H-2 
Table 3. Inhibition of EA Rosettes by Anti H-2 Sera 
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Ant iserum Anti I a Percent Roset te-Forming Cells a 
Activity 
Present BI0-BR(H-2k) B10.D2(H-2d) BI0(H-2b) 
Normal  CBA/H serum 1/50 - 
A CBA/H anti BALB/c 1/50 + 
(H-U anti H-2 d) 
B CBA/H anti P-815Y 1/50 - 
(H-2 k anti H-2 d) 
C CBA/H an t i -MethA 1/50 - 
(H-2 k anti-H-2 d) 
50.8•  43.4•  49.2+3.1 
54.6•  2.5+_0.9 21.5+1.5  
48.5+_5.6 4.8+_1.2 39.0+_2.8 
48.5+_1.0 1.0• 20.5•  
" Spleen cells pretreated with antiserum and washed. 
against H-2 D, H-2 K, and Ia antigens. Preincubation with antiserum A (anti-H-2 d) 
completely blocks EA rosette formation by B10.D2 (H-2 d) but has no effect 
on B 10. B R (H-2 k) cells. The intermediate effects on the B 10 (H-2 b) cells is predicted 
from the public (and Ia) specific• shared between H-2 d and H-2 b (Dbmant 
1973, Shreffler and David 1975). To assess the importance of anti-Ia activity 
on the inhibition observed, the anti-H-2 sera raised were tested against the Ia- 
negative tumor cells mastocytoma P815Y and T-cell lymphoma Meth A ~. Both 
of these antisera (B and C) strongly inhibited EA rosette formation (Table 3) 
suggesting that antibody against H-2 D or H-2 K antigens can inhibit EA rosette 
formation. 
Inhibition of EA Rosettes by Anti-sera Against H-2 K, Ia, or H-2 D antigens. 
To establish conclusively the specificity of the inhibitory activity in anti-H-2 
sera, well-defined sera were assessed with restricted specificity against panels 
of lymph node cells from strains selected to express all, some, or none of the 
immunizing H-2 antigens. The results are shown in Tables 4, 5, 6, and 7. 
Table4.  Specificity of  EA Rosette Inhibition by Anti H-2 Sera 
Source of Test Cells Percent Roset te-Forming Cells 
Strain Relevant H-2 Antigens Control 
H-2K Ia H-2D 
8 23 1 2 6 15 4 
After Treatment  with Antiseruma 
H D F 
(Anti- (Anti- (Anti- 
H-2D.4, H-2K.8, H-2K.23, 
la.6) Ia.l)  Ia.1, 2,15) 
B10 24.5+_2.9 27.5_+2.0 25.5+_3.0 26.7+_1.8 
B10.A + + + + + + + 25.1+_1.2 2.0_+1.1 3.0+-1.7 3.4+_0.4 
BI0.A(2R) + + + + + + - 19.9+_ 1.5 21.1 +_2.5 3.2+-1.0 1.1+-0.3 
A.TL + + - + + 18.6+-3.3 3.4+_1.5 19.7_+2.9 14.1+_2.3 
a Lymph node cells were preincubated at serum concentration 1 : 50 for 30 minutes at room tempera- 
ture. The cells were then washed once and the rosette assay was performed. 
1 These H - 2  d tumors  did not have Ia.6, 7 or 15 when tested in a complement-dependent  lysis 
assay (CDL). Al though small amounts  of  anti-Ia antibody might still theoretically occur, due to 
the small numbers  of  lymphocytes contaminat ing the injected tumor  cells, the authors  have not  
been able to demonstrate  such reactions in appropriate recombinant  mice. 
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Table 5. Specificity of  EA Rosette Inhibition by Anti H-2 Sera 
Source of Test Cells 
Strain Relevant H-2 Antigens 
H-2K la H-2D 
- 3 6 15 4 13 42 
Percent Rosette-Forming Cells 
Control After Treatment with Antiserum" 
L G H I 
(Anti- (Anti- (Anti- (Anti- 
Ia.3) H-2D.4, H-2D.4, H-2D.4, 






+ + + 
24.5_+2.4 1.1_+0.6 23.0_+2.2 23.5_+2.3 26.7_+1.2 
22.8__+1.3 22.5__+1.1 14.8_+3.3 23.1__+3.9 14.8-+0.9 
25.0_+1.4 22.8-+2.4 2.0-+0.6 4.8__+0.9 1.2-+0.6 
a See footnote a, Table 4. 
Table 6. Specificity of EA Rosette Inhibition by Anti H-2 Sera 
Source of Test Cells 
Strain Relevant H-2 Antigens 
Percent Rosette-Forming Cells 
Control After treatment with Antiserum" 
H-2K la H-2D M G H E 
(Anti- (Anti- (Anti- (Anti- 
31 6 7 11 15 16 4 13 Ia.7,15) H-2D.4, H-2D.4, H-2K.31, 
13) Ia.6) f a l l ,  16) 
BI0 26.8_+0,8 27.8_+2.6 26.2_+0.6 28.6_+0.2 28.4_+3.6 
B10.D2 + + + + + + + + 31.8_+0,9 8.6_+0.7 3.2_+0.4 6.1_+0.7 0.9_+0.2 
HTG + + + + + + 19.7_+0.8 6.7_+2.0 19.4_+4.5 17.7_+3.5 1.4_+0.8 
BI0.T(6R) - + + + 24.1_+0.5 25.8_+1.6 3.0_+1,8 8.0_+0.7 20.0_+3.4 
DBA/I - + - + 20.5_+1 17.4_+2.4 4.0_+0.5 19.0_+0.5 13.0_+1.9 
" See footnote a, Table 4. 
EA rosette inhibition by anti-H-2 K antibody is shown by serum D (anti-H- 
2K.8;  Table 4). The weak anti-Ia.1 activity in this serum is undetectable at the 
dilution tested. Furthermore, with antiserum E (anti-H-2 K.31, Ia. 11, 16; Table 6) 
and serum F (anti-H-2K.23, la.1, 2, 15; Table 4) cells with the relevant H-2 K 
antigens are clearly inhibited more strongly than are cells lacking some or all 
of these antigens. With serum E however, the relative importance of H-2K.31 
and Ia. l l  in producing the inhibition observed cannot be resolved. The activity 
in this serum previously felt to be H-2 K.34 is now attributed to Ia. 16 (N. Staines, 
personal communication). 
The ability of anti H-2D sera to inhibit EA-rosettes is demonstrated by 
serum G (anti H-2 D.4, 13, 42; Tables 5 and 6); serum H (anti-H-2 D.4; Tables 4, 
5, and 6); serum I (anti-H-2D.4, 13, 42; Ia.15; Table 5); and serum J (anti-H- 
2 D.28, 29; Table 7). Only antibody against D-region antigens can account for 
the pattern of  inhibition observed. Serum G is particularly important since it 
was not raised across any known/-region differences. 
Antibody raised against some D-region antigens can react with similar antigens 
in the K region. The occurence of such a result in rosette inhibition is shown 
by serum K (anti H-2KD.1 ; Table 7). As with serum G the raising of this serum 
r t ;  ~ x u t ; c p t O l  l l l l l l l ) l U O l l  roy /5.11[,1 F 1 - A  3 2 , 3  
T a b l e  7. Specif ic i ty  o f  E A  Rose t t e  I nh ib i t i on  by  Ant i  H - 2  Sera  
S o u r c e  o f  Test  Cells Pe rcen t  R o s e t t e - F o r m i n g  Cells  
S t r a in  R e l e v a n t  H-2  A n t i g e n s  C o n t r o l  A f t e r  T r e a t m e n t  wi th  A n t i s e r u m  a 
H - 2 K  Ia  H - 2 D  J K 
1 1 28 29 32 ( A n t i - H - 2 D ,  ( A n t i - H - 2 D , 3 2 ,  
28, 29) H - 2 K D . 1 )  
B 1 0 . D 2  - - - + + 2 4 . 1 •  8 . 3 •  2 2 . 5 •  
B 1 0 . B R  + --  + + 2 5 . 6 •  2 3 . 5 •  1 . 6 •  
B10 .A  + - --  + + - 2 0 . 8 •  4 . 8 •  4 . 5 •  
B 1 0 . A K M  + - + + + - 2 0 . 0 •  2 . 8 •  7 . 0 •  
a See f o o t n o t e  a, T a b l e  4. 
involved no known/- reg ion  differences and no known Ia-Antigen differences. 
The inhibition of EA-rosette formation by anti-Ia antisera has been previously 
reported (Schirrmacher et al. 1975 a) and is re-emphasized by the results obtained 
with serum L (anti-Ia.1, 2, 3, 7, 15; Table 5) and serum M (anti-Ia,1, 2, 7, 15; 
Table 6). Several other reactions in the anti-H-2 sera shown in these tables may 
be attributed to Ia activity. 
Thus all anti-H-2 sera in which antibody was easily demonstrable by conven- 
tional methods (CDL) produced specific inhibition of EA rosettes, irrespective 
of whether the antibody was directed against K-, /-, or D-region antigens. No 
unique association between EA rosette inhibition and antibody against I-region 
antigens was found in our system. 
Comparison of lgG and F(ab')2 Preparations of Anti-H-2 Sera in EA Rosette 
Inhibition. To show that inhibition of rosette formation was due to direct binding 
of the antibody combining sites to the RFC, the IgG and F(ab')2 preparations 
of various anti H-2 antisera were tested in parallel. The results, illustrated in 
Fig. 2, showed that there were no significant differences between the inhibitory 
potency of the intact IgG molecules and that of their F(ab')2 fragments. This 
was true whether the antibody was directed against Ia(a), H-2 D(b), or H-2 K(c) 
antigens. 
The Inhibition of RFC Obtained from Different Tissues by Anti-H-2 Antisera. 
Table 8 illustrates an experiment in which cells from various tissues (thymus, 
lymph node, spleen and bone marrow) were preincubated with antiserum and 
then assessed for their ability to form EA rosettes. Bone marrow cells were 
of particular interest because the great majority lack la antigens (McDevitt et 
al. 1974). RFC from lymph node and spleen cells were almost completely inhibited 
by either anti-Ia serum (L) or anti-H-2 D serum (G). The RFC of bone marrow 
were also inhibited by anti H-2D serum, but they were not inhibited by anti-Ia 
serum. Similar results were obtained when anti-H-2K and -Ia antisera were 
c o m p a r e d - t h e  anti-H-2K serum (E) strongly inhibited bone marrow RFC, 
whereas anti-la did not. These results show that (a) our anti-H-2K and anti 
H-2 D sera do recognise antigens, the tissue distribution of which conforms with 
that of the conventional H-2K and H-2D antigens, not with that of the Ia 
antigens; (b) the Fc receptor on the bone marrow RFC is not associated with 
Ia antigens. 
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control  strain test  strain 
o 
o~ 











(a) anti la 
i -  
1/20 1/20 1/200 1/2000 dilution 
Fig. 2. Comparison of  the EA rosettes observed with lymph node cells after no treatment (broken 
lines) or after t reatment  with the IgG preparation (stippled bars) or the F(ab')2 preparation (hatched 
bars) of  various antisera. (a) Anti-Ia (serum M); the control strain was BI0 and the test strain 
was BI0.A; (b) Ant i -H-2D (serum G); the control strain was Bl0 and the test strain was BI0.D2; 
(c) Ant i -H-2K (serum E); the control strain was B10 and the test strain was BI0.D2. This serum 
also contains anti-Ia activity 
Table 8. Inhibition of Rosette-Forming Cells from Different Tissues of  BI0.A Mice by Anti-H-2 Sera 
Source of Cells Percent Rosette-Forming Cells 
Control After Treatment  with Antiserum " 
L G 
(la 1,2,3,7,151 (Anti-H-2D.4,13) 
Thymus  0.2 • (1.2 NT b NT 
Lymph node 33.3_+6.3 1.8_+ 1.0 2.4_+ 1.0 
Spleen 46.0 _+ 3.6 6,0 • 1.9 2.7 _+ 0.6 
Bone marrow 40.6 + 2.7 39.6 _+ 1.0 4.1 • 1.2 
See footnote a, Table 4. b N T = n o t  tested. 
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Table9. Comparison of Cytotoxicity Inhibit ion and EA Rosette Inhibit ion by Antisera 
Antiserum Tested Inhibition of Antibody-Dependent Inhibit ion of 
Cell-Mediated Cytotoxicity" EA Rosettes b 
IgG F(ab')2 lgG F(ab')2 
Alloantisera 
(a) anti-H-2 
A anti-H-2K or D + - 
B anti-Ia + - 
(b) anti-Thy 1.2 + - 
(c) anti-Ly 4.2 + - 
Rabbit  Anti-MIg + - 
Rabbit  Anti-MBLA + - 
Rabbit  Anti-BA 0 d + - 
+ + 
+ + 
+ +c  
+ + 
+ + 
a Using spleen effector cells (Halloran etal. 1974). 
b Using lymph node or spleen RFC. 
c Schirrmacher and Hallovan, 1975, manuscript in preparation. 
d BA 0 = b r a i n  associated Thy-1 (0). 
Discussion 
Inhibition of an Fc receptor-dependent assay by antibody against the Fc 
receptor-bearing cells may be due to several potential mechanisms: (a) the anti- 
body may be binding to the Fc receptor by its Fc portion; (b) the antibody 
may be producing membrane changes that could alter the ability of the Fc receptor 
to bind; (c) the antibody might bind to a site on the cell membrane remote 
from the Fc receptor, but might still be able to exert steric effects, particularly 
in assays where the binding of large aggregates or erythrocytes was required; 
(d) the antibody might be binding directly to antigens intimately associated with 
the Fc receptor. Until one establishes which of these mechanisms is causing 
the inhibition of an Fc receptor-dependent event one cannot assign an immuno- 
genetic significance to the phenomenon. 
There are numerous techniques for the detection of Fc receptors: (a) EA 
rosettes (Cline et al. 1972), (b) binding of labeled immune complexes (Basten 
et al. 1972a,b, Yoshida and Anderson 1972, Eden et al. 1973) or aggregated 
IgG (Dickler and Sachs 1974, Anderson and Grey 1974); (c) binding of antibody- 
coated erythrocytes to tissue se.ctions (hemabsorption) (Tonder and Thunold 
1973); (d) inhibition of reverse 'immune cytoadherence (RICA) (Paraskevas et 
al. 1972 a); (e) ingestion of antibody-coated erythrocytes by macrophages (Hol- 
land et al. 1972); (f) antibody-dependent cell-mediated cytotoxicity (ADCC; Mac- 
Lennan et al. 1973). The homogeneity of the Fc receptors detected by these 
different assays has not been established. 
In many of these systems antibodies directed against the Fc receptor-bearing 
cell population have been reported to inhibit Fc receptor-binding in vitro. The 
inhibition of aggregated immunoglobulin or immune complex binding by anti-Ia 
sera and their Fab fragments has been mentioned in the introduction. In rats, 
EA rosettes have been inhibited by anti-AgB antibody (Parish and Hayward 
1974b). Heterologous antihuman lymphoma serum inhibited hemabsorption to 
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human lymphoma tissue (Tonder and Thunold 1973), and heterologous antimouse 
lymphocyte serum has been reported to inhibit the detection of Fc receptors 
by the RICA inhibition technique (Paraskevas et al. 1972 b). A variety of heterolo- 
gous antisera inhibit the ingestion of antibody-coated erythrocytes by macro- 
phages, apparently by an Fc-dependent mechanism (Holland et  al. 1972). The 
relationship of each of these phenomena to the others is not clear, and at least 
two different mechanisms may be operating: an Fc-dependent mechanism, as 
in the inhibition of phagocytosis, and an Fc-independent mechanism, as in the 
inhibition of aggregate binding by anti-Ia sera. 
In previous studies of antibody-dependent cell-mediated cytotoxicity, we have 
reported that antibody against a wide variety of cell-membrane antigens produced 
inhibition when allowed to interact with the effector cell population (Halloran 
and Festenstein 1974, Halloran et  al. 1974). The mechanism of this inhibition 
seemed to involve the formation of antibody-cell complexes, the Fc portions 
of which bound to the Fc receptor of the effector cell to inhibit cytotoxicity. 
The F(ab') 2 fragments of these antibodies, including anti-Ia antibodies, produced 
no inhibition (Schirrmacher et  al. 1975a,b). As mentioned in the Introduction, 
a wide variety of antibodies against B cells inhibited EA rosette formation by 
lymph node and spleen cells, but in contrast to the situation with cytotoxicity 
inhibition, the F(ab')2 fragments of these antibodies also produced strong EA 
rosette inhibition. The present studies were undertaken to establish whether the 
inhibition observed with antisera against H-2 antigens could be exclusively due 
to antibody against I-region antigens. 
The EA rosette forming cells in our system are of two varieties: (a) a B 
lymphocyte, which represents the vast majority of RFC in lymph node and 
spleen, as shown by tissue distribution, nylon fiber column removal, resistance 
to anti-Thy-1 and complement treatment (unpublished results), and inhibition 
by antibodies against B cells (MBLA; MIg; Ia; Ly 4.2) but not by antibodies 
against T cells (Schirrmacher et  al. 1975b); (b) a population of bone marrow- 
derived cells, usually large and blast like, the properties of which are under investi- 
gation but which probably belong to the myeloid lineage of cells. In this report 
antibodies against K- or D-region antigens have been shown to inhibit both 
of these types of RFC but that antibodies against/-region antigens can inhibit 
only the B-lymphocyte RFC. This corroborates previous observations about 
the absence of/-region antigens on the vast majority of bone marrow cells. 
It may be pertinent that small numbers of cells in spleen, and to a lesser extent 
in lymph nodes, are resistant to inhibition, especially with anti-la antisera, and 
probably represent other cell types (particularly macrophages). 
The mechanism of inhibition of EA-RFC by anti-H-2 or other antisera is 
not known. It is independent of the Fc portion of the inhibiting antibody, since 
the F(ab')2 fragment is equal, or almost equal, to the whole IgG molecule (Fig. 2). 
Furthermore, it cannot be attributed to identity between cell-surface antigens 
and Fc receptors, because antibodies to such a wide variety of independent 
antigens have been shown to be inhibitory. Metabolic activity seems unnecessary, 
since the reaction can occur at 4~ Steric hindrance of cell-to-cell contact is 
a possible explanation, yet it fails to account for the failure of antisera, which 
inhibit EA rosettes, to inhibit complement-receptor rosettes (Parish and Hayward 
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1974, Dickler and Sachs 1974) or rosettes formed between B cells and anti-im- 
munoglobulin-coated erythrocytes (Parish and Hayward 1974). A completely 
satisfactory explanation is probably not possible at present. 
We emphasize the difference between the inhibition of EA rosettes by antisera 
and the inhibition of  ADCC by similar antisera (the cytotoxicity inhibition assay 
or CIA), as summarized in Table 9. Whether these differences reflect differences 
in the conditions of the two assays, in the cells bearing the Fc receptors, or 
in the structure or behavior of the Fc receptors themselves is an interesting 
but unresolved question. Particularly attractive is the possibility that the Fc 
receptors detected in cytotoxicity and those detected in EA rosette formation 
may have different functional properties. 
As reported by Dickler and Sachs (1974), binding of aggregated Ig to the 
B-cell Fc receptor could not be inhibited by antibody against H-2K or H-2D 
antigens, but only by antibody against Ia antigens. In contrast, we have found 
that antibody against some antigens apparently mapping in the K or D regions 
is as effective as antibody against/-region antigens in the EA rosette-inhibition 
assay when the RFC is a B lymphocyte. Definitive interpretation of the results, 
particularly for the H-2K antigens, is complicated by the recent rapid changes 
in the understanding of serological specificities in the H-2 system. Some specifici- 
ties currently believed to be H-2K antigens are being reassessed as /-region 
antigens, and the knowledge of crossover positions in recombinant mice is still 
developing. It may be assumed that some of the antisera employed in the studies 
reported herein will contain antibody against currently unknown/-region antigens. 
But can the inhibition observed with the antisera against H-2 K and H-2D 
antigens be attributed to undiscovered Ia antigens? Certainly the reactions of 
the antisera against D-end antigens with cells from the recombinants between 
the S and D regions [B10.A(2R), BI0.T(6R), B10.S(7R), B10.AKM and HTG] 
cannot be attributed to /-region antigens. Nor can /-region antigens account 
for the crossreaction shown between the D-end and K-end antigens in our results. 
The strong inhibition shown with anti-H-2 sera raised against Ia-negative tumor 
cells, and the ability of antisera against K- and D-region antigens to inhibit 
bone marrow RFCs (most of which lack Ia antigens and which are not inhibited 
by anti-Ia antisera) must imply that the antigens detected lack the restricted 
tissue distribution characteristic of Ia antigens. The only coherent explanation 
of all of  these results is that antibody against at least some K- and D-region 
antigens, as well as antibody against /-region antigens, against MBLA, Ly 4.2, 
and mouse immunoglobulin, can inhibit EA rosette formation. Whether antibody 
against every cell-surface antigen on the rosette-forming cell can mediate EA 
rosette inhibition in our system and whether the H-2 K and H-2 D antigens in- 
volved are the same as those expressed on red cells, cannot be resolved at present. 
In concluding, we would like to emphasize certain points of immunogenetic 
interest. First, conclusions about the Fc receptor and its relationship to Ia antigens 
are difficult to assess by inhibition data alone. The fact that antisera against 
many different surface antigens inhibit our EA rosette system does not deny 
that in another type of EA rosette or aggregate-binding system, antibody against 
Ia antigens may have unique characteristics. But until the mechanism of the 
inhibition of Fc receptors in the various systems is resolved, concluding that 
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the Fc receptor is uniquely associated with/ -region gene products is hazardous. 
Certainly it would now seem that Fc receptors which are not inhibited by anti-Ia 
antibody, are present on several cell types: bone marrow cells (this report); 
cytotoxic effector cells (Schirrmacher et al. 1975b); and some tumor cells (P.H., 
unpublished; Ramasamy and Munroe, personal communication). 
Second, most antisera that reacted with the rosette-forming cells in conven- 
tional assays have thus far inhibited EA-rosette formation, suggesting that this 
EA-rosette inhibition may prove to be a convenient method for studying cell- 
surface antigens on various kinds of  EA rosette-forming cells. For example, 
we are currently employing this method to study cell-surface antigens on the 
subpopulation of activated T cells, which expresses Fc receptors (Yoshida and 
Anderson 1972). 
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